TGFB1 and neoplasm: According to this hypothesis, orthotopic and metastatic tumor tissues expressed TGF-β but only the orthotopic tumor expressed a relevant amount of pSMAD 2/3, indicating activation of the TGF-β pathway (Figure 4B).